Madrigal Pharmaceuticals Inc banner

Madrigal Pharmaceuticals Inc
F:YDO1

Watchlist Manager
Madrigal Pharmaceuticals Inc Logo
Madrigal Pharmaceuticals Inc
F:YDO1
Watchlist
Price: 452 EUR -1.85% Market Closed
Market Cap: €9.6B

Wall St Price Targets

YDO1 Price Targets Summary
Madrigal Pharmaceuticals Inc

Wall Street analysts forecast YDO1 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for YDO1 is 481.08 EUR with a low forecast of 379.82 EUR and a high forecast of 719.55 EUR.

Lowest Forecast
Price Target
379.82 EUR
16% Downside
Average Forecast
Price Target
481.08 EUR
6% Upside
Highest Forecast
Price Target
719.55 EUR
59% Upside
Madrigal Pharmaceuticals Inc Competitors:
Price Targets
VERK
Verkkokauppa.com Oyj
36% Upside
PTCT
PTC Therapeutics Inc
21% Upside

Revenue
Forecast

41% / Year
Past Growth
26% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
41% / Year
Past Growth
26% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

Over the last 14 years, the compound annual growth rate for Revenue has been 41%. The projected CAGR for the next 8 years is 26%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-38%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-38%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is YDO1's stock price target?
Price Target
481.08 EUR

According to Wall Street analysts, the average 1-year price target for YDO1 is 481.08 EUR with a low forecast of 379.82 EUR and a high forecast of 719.55 EUR.

What is the Revenue forecast for Madrigal Pharmaceuticals Inc?
Projected CAGR
26%

Over the last 14 years, the compound annual growth rate for Revenue has been 41%. The projected CAGR for the next 8 years is 26%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett